Retreatment Efficacy of Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir  + Ribavirin for Hepatitis C Virus Genotype 4 Patients

ConclusionsThe recent multi-targeted regimen of SOF plus OBV/PTV/r  + RBV was well tolerated and achieved excellent SVR rates among retreatment-experienced Egyptian patients with prior DAA treatments failure, thus providing an alternative regimen for the retreatment of difficult-to-cure HCV GT4 patients.

Source: Digestive Diseases and Sciences - March 15, 2018 Category: Gastroenterology Source Type: research